Abstract:ABSTRACT The type 3 secretion system (T3SS) is essential for bacterial virulence through delivering effector proteins directly into the host cytosol. Here, we identified an alternative delivery mechanism of virulence factors mediated by the T3SS, which consists of the association of extracellularly secreted proteins from bacteria with the T3SS to gain access to the host cytosol. Both EspC, a protein secreted as an enteropathogenic Escherichia coli (EPEC) autotransporter, and YopH, a protein detected on the surface of Yersinia , require a functional T3SS for host cell internalization; here we provide biophysical and molecular evidence to support the concept of the EspC translocation mechanism, which requires (i) an interaction between EspA and an EspC middle segment, (ii) an EspC translocation motif (21 residues that are shared with the YopH translocation motif), (iii) increases in the association and dissociation rates of EspC mediated by EspA interacting with EspD, and (iv) an interaction of EspC with the EspD/EspB translocon pore. Interestingly, this novel mechanism does not exclude the injection model (i.e., EspF) operating through the T3SS conduit; therefore, T3SS can be functioning as an internal conduit or as an external railway, which can be used to reach the translocator pore, and this mechanism appears to be conserved among different T3SS-dependent pathogens. IMPORTANCE The type 3 secretion system is essential for injection of virulence factors, which are delivered directly into the cytosol of the host cells for usurping and subverting host processes. Recent studies have shown that these effectors proteins indeed travel inside an “injectisome” conduit through a single step of translocation by connecting the bacterium and host cell cytoplasms. However, all findings are not compatible with this model. For example, both YopH, a protein detected on the surface of Yersinia , and EspC, an autotransporter protein secreted by enteropathogenic E. coli , require a functional T3SS for host cell translocation. Both proteins have an intermediate extracellular step before their T3SS-dependent translocation. Here, we show an alternative delivery mechanism for these extracellularly secreted virulence factors that are then incorporated into the T3SS to enter the cells; this novel mechanism coexists with but diverges from the canonical injection model that involves the passage of the protein inside the injectisome.

Protein-Injection Machines in Bacteria

Genome-wide Identification and Characterization of a Superfamily of Bacterial Extracellular Contractile Injection Systems

Features and Algorithms: Facilitating Investigation of Secreted Effectors in Gram-negative Bacteria.

Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells

In Situ Molecular Architecture Of The Salmonella Type Iii Secretion Machine

T3S injectisome needle complex structures in four distinct states reveal the basis of membrane coupling and assembly

Type III protein secretion systems in bacterial pathogens of animals and plants

Heterologous Assembly of the Type VI Secretion System Empowers Laboratory Escherichia coli with Antimicrobial and Cell Penetration Capabilities

Secretion systems in Gram-negative bacteria: structural and mechanistic insights

Programmable protein delivery with a bacterial contractile injection system

The expanding universe of contractile injection systems in bacteria

Bacterial Contact-Dependent Delivery Systems

Evolutionary and ecological role of extracellular contractile injection systems: from threat to weapon

A bacterial type III secretion-based protein delivery tool for broad applications in cell biology

A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins

Engineering Escherichia coli into a Protein Delivery System for Mammalian Cells

Mix-and-match tools for protein injection into cells

Bsp22 protein polymerization drives dynamic adaptation of the type III secretion system injectisome

A genomic and structural bioinformatic pipeline identifies candidate type VI secretion antibacterial effector-immunity pairs

Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery

Protein Export via the Type III Secretion System of the Bacterial Flagellum